Strive’s all-stock merger with Semler Scientific cements Bitcoin strategy
Asset manager Strive has reached an agreement to purchase Bitcoin-focused Semler Scientific in a fully equity-based rather than cash-based deal.
Under the terms announced Sept. 22, each Semler Scientific share will convert into 21.05 Strive Class A common shares, valuing the target at $90.52 per share. That price represents a premium of more than 200% compared with its recent market value.
The merger outlines a two-track plan for the future company. Semler’s well-established diagnostic line could be monetized directly or spun out to deliver shareholder returns.
At the same time, Strive and Semler leaders plan to broaden the scope of preventative diagnostics, with a new management team guiding the transition.
Strive’s current directors…
